Cue Biopharma has appointed Shao-Lee Lin as CEO, President and Director. Lin will succeed Lucinda Warren, Interim President ...

LEO Pharma has announces that it will acquire Replay, a gene therapy company focused on developing transformative treatments ...

Eli Lilly has announced an additional investment of $4.5bn across two of its three sites in Indiana in the US, bringing the company’s total Indiana capital expansion commitments since 2020 to more ...

Langland has appointed Victoria Kent as Managing Partner, Medical Strategy & Education, with responsibility for all medical ...

GC Therapeutics has appointed Stefan Irion as Chief Scientific Officer (CSO). Irion brings more than two decades of experience translating stem cell science into clinical stage therapeutics. In his ...

The US FDA has granted Rare Paediatric Disease (RPD) designation for Satellite Bio’s SB-101 for the treatment of urea cycle disorders (UCDs)., Satellite Bio is a biotechnology company developing ...

We’re delighted that Amiculum has become a member of Bionow, joining a collaborative community that plays an important role ...

Angelini Pharma has announced that it will acquire Catalyst Pharmaceuticals in a deal worth around $4.1bn (3.5bn euros).

Against the backdrop of widespread medicine shortages, Durbin PLC’s rebrand to Uniphar and integration into Uniphar | Global Sourcing represents a strategic move to address industry-wide challenges, ...

Integrated capabilities combining advanced analytics, pharmacy, and specialized talent to improve access, affordability, and ...

Cuttsy+Cuttsy is happy to be welcoming three new people to the team this month. Cuttsy+Cuttsy is happy to be welcoming three new people to the team this month. Explore real patient conversations about ...

Did you know? Over 320,000 learners have engaged with heart failure content on Medscape. With such an enthusiastic audience ...